Comparative associations between anticholinergic burden and emergency department visits for anticholinergic adverse events in older Korean adults: a nested case-control study using national claims data for validation of a novel country-specific scale

被引:7
作者
Hwang, Sunghee [1 ,2 ]
Chung, Jee Eun [1 ,2 ]
Jun, Kwanghee [3 ,4 ]
Ah, Young-Mi [5 ]
Kim, Kwang-Il [6 ]
Lee, Ju-Yeun [3 ,4 ]
机构
[1] Hanyang Univ, Coll Pharm, Ansan, Gyeonggi Do, South Korea
[2] Hanyang Univ, Inst Pharmaceut Sci & Technol, Ansan, Gyeonggi Do, South Korea
[3] Seoul Natl Univ, Coll Pharm, Seoul, South Korea
[4] Seoul Natl Univ, Res Inst Pharmaceut Sci, Seoul, South Korea
[5] Yeungnam Univ, Coll Pharm, Gyongsan, Gyeongsangbuk D, South Korea
[6] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seognam Si, Gyeonggi Do, South Korea
基金
新加坡国家研究基金会;
关键词
Anticholinergic syndromes; Cholinergic antagonists; Emergency medical services; Geriatrics;
D O I
10.1186/s40360-020-00467-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background Considering the limited generalizability of previous anticholinergic burden scales, the Korean Anticholinergic Burden Scale (KABS) as a scale specific to the Korean population was developed. We aimed to validate the KABS by detecting the associations between high anticholinergic burden, measured with the KABS, and emergency department (ED) visits compared to the pre-existing validated scales in older Korean adults. Methods A nested case-control study was conducted using national claims data. The cases included the first anticholinergic ED visits between July 1 and December 31, 2016. Anticholinergic ED visits were defined as ED visits with a primary diagnosis of constipation, delirium, dizziness, fall, fracture, or urinary retention. Propensity score-matched controls were identified. Average daily AB scores during 30 days before the index date were measured. Multivariate logistic regression analyses were performed. Results In total, 461,034 were included. The highest proportion of those with high AB was identified with KABS (5.0%). Compared with those who had a KABS score of 0, older adults with a score >= 3 were at higher risk for overall anticholinergic ED visits (aOR, 1.62, 95% CI, 1.53-1.72), as well as visits for falls/fractures (aOR: 1.54, 95% CI: 1.40-1.69), dizziness (aOR: 1.44, 95% CI: 1.30-1.59), delirium (aOR: 2.96, 95% CI: 2.28-3.83), constipation (aOR: 1.84, 95% CI: 1.68-2.02), and urinary retention (aOR: 2.13, 95% CI: 1.79-2.55). High AB by KABS showed a stronger association with overall anticholinergic ED visits and visits due to delirium and urinary retention than those by other scales. Conclusions In conclusion, KABS is superior to pre-existing scales in identifying patients with high AB and predicting high AB-related ED visits in older Korean adults.
引用
收藏
页数:8
相关论文
共 27 条
  • [11] Drugs and falls in older people: A systematic review and meta-analysis: I. Psychotropic drugs
    Leipzig, RM
    Cumming, RG
    Tinetti, ME
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1999, 47 (01) : 30 - 39
  • [12] Expert-based drug lists to measure anticholinergic burden: similar names, different results
    Lertxundi, Unax
    Domingo-Echaburu, Saioa
    Hernandez, Rafael
    Peral, Javier
    Medrano, Juan
    [J]. PSYCHOGERIATRICS, 2013, 13 (01) : 17 - 24
  • [13] A model to classify the sedative load of drugs
    Linjakumpu, T
    Hartikainen, S
    Klaukka, T
    Koponen, H
    Kivelä, SL
    Isoaho, R
    [J]. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2003, 18 (06) : 542 - 544
  • [14] Systematic review on the use of anticholinergic scales in poly pathological patients
    Ma Villalba-Moreno, Angela
    Rocio Alfaro-Lara, Eva
    Concepcion Perez-Guerrero, Ma
    Dolores Nieto-Martin, Ma
    Santos-Ramos, Bernardo
    [J]. ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2016, 62 : 1 - 8
  • [15] Comparison of Nine Instruments to Calculate Anticholinergic Load in a Large Cohort of Older Outpatients: Association with Cognitive and Functional Decline, Falls, and Use of Laxatives
    Mayer, Tanja
    Meid, Andreas Daniel
    Saum, Kai-Uwe
    Brenner, Hermann
    Schoettker, Ben
    Seidling, Hanna Marita
    Haefeli, Walter Emil
    [J]. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2017, 25 (05) : 531 - 540
  • [16] Different methods, different results-how do available methods link a patient's anticholinergic load with adverse outcomes?
    Mayer, Tanja
    Haefeli, Walter E.
    Seidling, Hanna M.
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 71 (11) : 1299 - 1314
  • [17] Anticholinergics: theoretical and clinical overview
    Nishtala, Prasad S.
    Salahudeen, Mohammed Saji
    Hilmer, Sarah N.
    [J]. EXPERT OPINION ON DRUG SAFETY, 2016, 15 (06) : 753 - 768
  • [18] Quality of Drug Prescribing in Elderly People in Nursing Homes and Special Care Units for Dementia
    Olsson, Jonny
    Bergman, Asa
    Carlsten, Anders
    Oke, Thimothy
    Bernsten, Cecilia
    Schmidt, Ingrid K.
    Fastbom, Johan
    [J]. CLINICAL DRUG INVESTIGATION, 2010, 30 (05) : 289 - 300
  • [19] Association of Anticholinergic Burden with Cognitive and Functional Status in a Cohort of Hospitalized Elderly: Comparison of the Anticholinergic Cognitive Burden Scale and Anticholinergic Risk Scale Results from the REPOSI Study
    Pasina, Luca
    Djade, Codjo D.
    Lucca, Ugo
    Nobili, Alessandro
    Tettamanti, Mauro
    Franchi, Carlotta
    Salerno, Francesco
    Corrao, Salvatore
    Marengoni, Alessandra
    Iorio, Alfonso
    Marcucci, Maura
    Violi, Francesco
    Mannucci, Pier Mannuccio
    [J]. DRUGS & AGING, 2013, 30 (02) : 103 - 112
  • [20] Measuring anticholinergic drug exposure in older community-dwelling Australian men: a comparison of four different measures
    Pont, Lisa G.
    Nielen, Johannes T. H.
    McLachlan, Andrew J.
    Gnjidic, Danijela
    Chan, Lewis
    Cumming, Robert G.
    Taxis, Katja
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 80 (05) : 1169 - 1175